Artificial intelligence (AI) is revolutionizing prostate cancer genomics research. These AI-driven insights can lead to the discovery of novel biomarkers, enhance the accuracy of diagnosis, and predict disease progression and treatment response.
Understanding this could lead to better treatments, improved diagnostics, or a deeper grasp of how the human body works — benefiting patient care globally.
Read the full paper
Access the original peer-reviewed research via PubMed.
| Category | 🧬 Medicine & Biology |
| Published | Feb 01, 2024 |
| Journal | The Urologic clinics of North America |
| Authors | Wong Elyssa Y, Chu Timothy N, Ladi-Seyedian Seyedeh-Sanam |
| DOI | 10.1016/j.ucl.2023.06.006 |
| Source | PubMed |